Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma
- Resource Type
- Short Communication
- Source
- In
Respiratory Investigation September 2016 54(5):372-375 - Subject
- Language
- ISSN
- 2212-5345